(NASDAQ: SGHT) Sight Sciences's forecast annual revenue growth rate of 8.11% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.31%.
Sight Sciences's revenue in 2026 is $83,377,000.On average, 10 Wall Street analysts forecast SGHT's revenue for 2026 to be $4,837,000,962, with the lowest SGHT revenue forecast at $4,567,235,075, and the highest SGHT revenue forecast at $5,044,462,332. On average, 10 Wall Street analysts forecast SGHT's revenue for 2027 to be $5,380,939,775, with the lowest SGHT revenue forecast at $5,004,523,540, and the highest SGHT revenue forecast at $5,779,281,031.
In 2028, SGHT is forecast to generate $5,885,600,852 in revenue, with the lowest revenue forecast at $5,371,629,905 and the highest revenue forecast at $6,310,880,134.